Sumitomo Mitsui Trust Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-217,696	Closed	-$1.02M	–	1156
2020 Q1	$1.02M	Sell	217,696 -12,372	-5%	-$133K	﹤0.01%	933
2019 Q4	$2.97M	Sell	230,068 -5,560	-2%	-$51.3K	﹤0.01%	860
2019 Q3	$2.47M	Buy	235,628 +25,063	+12%	+$328K	﹤0.01%	857
2019 Q2	$3.58M	Buy	210,565 +104,481	+98%	+$2.83M	﹤0.01%	794
2019 Q1	$3.58M	Buy	+106,084	New	+$3.55M	﹤0.01%	745

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sumitomo Mitsui Trust Group's BLCM Position: Q2 2020 in Review

Sumitomo Mitsui Trust Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2020, closing a stake of 217,696 shares — an estimated $1.02M sold.

Sumitomo Mitsui Trust Group first reported a position in BLCM in Q1 2019 and held it in 5 quarters. The position peaked at $3.58M in Q2 2019. 27 funds tracked by Wall St. Rank hold BLCM as of Q2 2020.

Sumitomo Mitsui Trust Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Sumitomo Mitsui Trust Group sold 217,696 Bellicum Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.02M.
Sumitomo Mitsui Trust Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2019 and held it in 5 quarters.
Sumitomo Mitsui Trust Group's Bellicum Pharmaceuticals, Inc. position peaked at $3.58M in Q2 2019.
27 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2020.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2020, filed 27 Jul 2020.